Relapse Remitting Multiple Sclerosis (RRMS) is the most common type, affecting 85% of MS patients, involving episodes of new or increasing symptoms followed by periods of remission.
Age between 20 to 40 years old, being a woman, genetic factors, smoking, infections, vitamin D and B12 deficiency can increase the risk of Multiple Sclerosis.
Diagnosis of Multiple Sclerosis involves physical and neurological exam, MRI scans of the brain and spinal cord, CSF analysis through lumbar puncture, and evoked potential test (EPT).
Experimental Interventions include Plasma exchange, which removes antibodies in the blood, and Stem cell therapy, which aims to regenerate various blood body cells and restore function to those who have lost it.
Behavioral changes to Complementary treatment include Limiting screen time and resting eyes, resting when fatigued, and using assistive devices or putting weight to the limbs to reduce shaking.
The immune system attacks myelin, which causes inflammation and demyelination
Visual evoked response or potential (VER or VEP) is used when the eyes are stimulated by looking at a test pattern and is commonly used in multiple sclerosis diagnosis.
When visual evoked potentials (VERs) are recorded, the electrodes are applied to the rear (occipital region) of the scalp over the brain areas that register visual stimuli.
Abnormal results in evoked potential tests indicate that some people who are free from symptoms and the nerve area tested will still have abnormal responses in that area.
Lhermitte's sign is the hallmark of Multiple Sclerosis.
It is characterized as the sense of electricity that shoots up or down the spine; it is triggered when the chin is pointed down towards the chest.
The three types of Evoked Potential Tests are: Visually evoked response or potential (VER or VEP), Auditory brainstem evoked response or potential (ABER or ABEP), Somatosensory evoked response or potential (SSER or SSEP).